RPWE-1 (10,000 cells/well) cell viability was not altered by daily treatment of testosterone (0.1 nM–30 nM), dihydrotestosterone (0.03 nM–100 nM), or mibolerone (0.01 nM–20 nM) after a 5-day treatment period; no significant treatment effects.
figure
posted on 2013-02-20, 10:08 authored by Alexander B. Opoku-Acheampong, Michelle K. Nelsen, Dave Unis, Brian L. LindshieldRPWE-1 (10,000 cells/well) cell viability was not altered by daily treatment of testosterone (0.1 nM–30 nM), dihydrotestosterone (0.03 nM–100 nM), or mibolerone (0.01 nM–20 nM) after a 5-day treatment period; no significant treatment effects.
